ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 277 filers reported holding ICU MED INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,166,432 | -59.8% | 6,546 | -62.8% | 0.00% | -66.7% |
Q1 2023 | $2,900,327 | +420.7% | 17,582 | +375.6% | 0.01% | +300.0% |
Q3 2022 | $557,000 | -70.4% | 3,697 | -56.2% | 0.00% | -62.5% |
Q1 2022 | $1,880,000 | +22.2% | 8,445 | +30.2% | 0.01% | +100.0% |
Q4 2021 | $1,539,000 | -7.8% | 6,486 | -9.4% | 0.00% | -20.0% |
Q3 2021 | $1,670,000 | +619.8% | 7,155 | +534.3% | 0.01% | +400.0% |
Q2 2021 | $232,000 | -92.8% | 1,128 | -93.5% | 0.00% | -98.1% |
Q2 2020 | $3,220,000 | +6.1% | 17,472 | +45.0% | 0.05% | +73.3% |
Q2 2019 | $3,035,000 | +182.6% | 12,048 | +168.5% | 0.03% | +172.7% |
Q1 2019 | $1,074,000 | -48.0% | 4,487 | -50.1% | 0.01% | -54.2% |
Q4 2018 | $2,065,000 | -82.2% | 8,992 | -78.0% | 0.02% | -82.7% |
Q3 2018 | $11,575,000 | -4.7% | 40,936 | -1.0% | 0.14% | -13.7% |
Q2 2018 | $12,141,000 | +254.9% | 41,345 | +205.0% | 0.16% | +198.1% |
Q1 2018 | $3,421,000 | +304.9% | 13,554 | +176.7% | 0.05% | +217.6% |
Q2 2017 | $845,000 | -48.2% | 4,899 | -54.1% | 0.02% | -62.2% |
Q1 2017 | $1,630,000 | – | 10,672 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |